Ovarian CA screening potentially cost-effective in the U.S.
(HealthDay)—Multimodal screening (MMS) for ovarian cancer is potentially cost-effective in the United States, according to a study published online Dec. 7 in JAMA Oncology.
Dec 8, 2017
0
8